Lee Hyung Seok, Kim Sung Gyun
Division of Nephrology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.
Kidney Res Clin Pract. 2021 Mar;40(1):29-39. doi: 10.23876/j.krcp.20.144. Epub 2021 Mar 2.
The Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines are developed by the National Kidney Foundation in the United States; however, the guidelines have an impact on most international societies, including those in Korea. The KDOQI recently released the updated 2019 guidelines for vascular access based on numerous papers and controversies concerning vascular access since 2006, when the first guidelines were published. The new KDOQI guidelines have undergone significant changes compared to previous guidelines, including a change in the philosophy regarding a patient-centered approach using an end-stage kidney disease "Life-Plan." In addition, there are newly developed or revised definitions and some key differences from previous guidelines. The process of adapting guidelines needs to be individualized to hemodialysis practice in each country, while agreeing with general principles and philosophy; therefore, we summarize changes in the updated guidelines and discuss the application and implementation of the new principles and concepts of the guidelines for vascular access care in Korea.
美国国家肾脏基金会制定了《肾脏病预后质量倡议》(KDOQI)指南;然而,这些指南对包括韩国在内的大多数国际学会都有影响。KDOQI最近发布了2019年更新的血管通路指南,该指南基于自2006年首次发布指南以来众多关于血管通路的论文和争议。与之前的指南相比,新的KDOQI指南有了重大变化,包括在使用终末期肾病“生命计划”的以患者为中心的方法理念上的改变。此外,还有新制定或修订的定义以及与之前指南的一些关键差异。在认同一般原则和理念的同时,指南的适配过程需要根据每个国家的血液透析实践进行个体化;因此,我们总结了更新指南中的变化,并讨论了韩国血管通路护理指南新原则和概念的应用与实施。